Bio

Anuv Ratan (Menlo Park) joined KKR in 2017 and is a member of the Health Care industry team. At KKR, he has been involved with investments in Gamma Biosciences, Zeus Health, Nordic Bioscience, Ajax Health, Headlands Research, Aimmune Therapeutics, BrightSpring Pharmerica, Global Medical Response, and Impel Neuropharma. He is currently a member of the board of directors of Gamma Biosciences, Blue Sprig Pediatrics and Headlands Research. Prior to joining KKR, Mr. Ratan worked at FFL Partners, where he was involved in a number of health care transactions. Mr. Ratan began his career at The Blackstone Group. He holds an A.B., with honors, in Neurobiology from Harvard University.